These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30305341)

  • 1.
    Hisamatsu T; McGuire M; Wu SY; Rupaimoole R; Pradeep S; Bayraktar E; Noh K; Hu W; Hansen JM; Lyons Y; Gharpure KM; Nagaraja AS; Mangala LS; Mitamura T; Rodriguez-Aguayo C; Eun YG; Rose J; Bartholomeusz G; Ivan C; Lee JS; Matsuo K; Frumovitz M; Wong KK; Lopez-Berestein G; Sood AK
    Mol Cancer Ther; 2019 Jan; 18(1):162-172. PubMed ID: 30305341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Inhibition of the Receptor Tyrosine Kinase AXL Improves Sensitivity to Platinum and Taxane in Ovarian Cancer.
    Quinn JM; Greenwade MM; Palisoul ML; Opara G; Massad K; Guo L; Zhao P; Beck-Noia H; Hagemann IS; Hagemann AR; McCourt CK; Thaker PH; Powell MA; Mutch DG; Fuh KC
    Mol Cancer Ther; 2019 Feb; 18(2):389-398. PubMed ID: 30478151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential roles of human Dicer-binding proteins TRBP and PACT in small RNA processing.
    Lee HY; Zhou K; Smith AM; Noland CL; Doudna JA
    Nucleic Acids Res; 2013 Jul; 41(13):6568-76. PubMed ID: 23661684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
    Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
    Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Dicer in regulating oxaliplatin resistance of colon cancer cells.
    Lai HH; Lin LJ; Hung LY; Chen PS
    Biochem Biophys Res Commun; 2018 Nov; 506(1):87-93. PubMed ID: 30336979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p5RHH nanoparticle-mediated delivery of AXL siRNA inhibits metastasis of ovarian and uterine cancer cells in mouse xenografts.
    Mills KA; Quinn JM; Roach ST; Palisoul M; Nguyen M; Noia H; Guo L; Fazal J; Mutch DG; Wickline SA; Pan H; Fuh KC
    Sci Rep; 2019 Mar; 9(1):4762. PubMed ID: 30886159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-34a suppresses ovarian cancer proliferation and motility by targeting AXL.
    Li R; Shi X; Ling F; Wang C; Liu J; Wang W; Li M
    Tumour Biol; 2015 Sep; 36(9):7277-83. PubMed ID: 25895459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p/CDC5L/PEAK1 pathway.
    Zhang C; Li Y; Zhao W; Liu G; Yang Q
    Cancer Med; 2020 May; 9(10):3500-3521. PubMed ID: 32167655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagic degradation of SQSTM1 inhibits ovarian cancer motility by decreasing DICER1 and AGO2 to induce MIRLET7A-3P.
    Liao CC; Ho MY; Liang SM; Liang CM
    Autophagy; 2018; 14(12):2065-2082. PubMed ID: 30081720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer.
    Liu T; Zhang X; Du L; Wang Y; Liu X; Tian H; Wang L; Li P; Zhao Y; Duan W; Xie Y; Sun Z; Wang C
    Mol Cancer; 2019 Mar; 18(1):43. PubMed ID: 30890168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells.
    Bourguignon LY; Spevak CC; Wong G; Xia W; Gilad E
    J Biol Chem; 2009 Sep; 284(39):26533-46. PubMed ID: 19633292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dicer Elicits Paclitaxel Chemosensitization and Suppresses Cancer Stemness in Breast Cancer by Repressing AXL.
    Chang TY; Chen HA; Chiu CF; Chang YW; Kuo TC; Tseng PC; Wang W; Hung MC; Su JL
    Cancer Res; 2016 Jul; 76(13):3916-28. PubMed ID: 27216190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal miR-208b related with oxaliplatin resistance promotes Treg expansion in colorectal cancer.
    Ning T; Li J; He Y; Zhang H; Wang X; Deng T; Liu R; Li H; Bai M; Fan Q; Zhu K; Ying G; Ba Y
    Mol Ther; 2021 Sep; 29(9):2723-2736. PubMed ID: 33905821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of multidrug resistance 1 expression by CDX2 in ovarian mucinous adenocarcinoma.
    Koh I; Hinoi T; Sentani K; Hirata E; Nosaka S; Niitsu H; Miguchi M; Adachi T; Yasui W; Ohdan H; Kudo Y
    Cancer Med; 2016 Jul; 5(7):1546-55. PubMed ID: 27060927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic options for mucinous ovarian carcinoma.
    Gorringe KL; Cheasley D; Wakefield MJ; Ryland GL; Allan PE; Alsop K; Amarasinghe KC; Ananda S; Bowtell DDL; Christie M; Chiew YE; Churchman M; DeFazio A; Fereday S; Gilks CB; Gourley C; Hadley AM; Hendley J; Hunter SM; Kaufmann SH; Kennedy CJ; Köbel M; Le Page C; Li J; Lupat R; McNally OM; McAlpine JN; Pyman J; Rowley SM; Salazar C; Saunders H; Semple T; Stephens AN; Thio N; Torres MC; Traficante N; Zethoven M; Antill YC; Campbell IG; Scott CL
    Gynecol Oncol; 2020 Mar; 156(3):552-560. PubMed ID: 31902686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depletion of Dicer promotes epithelial ovarian cancer progression by elevating PDIA3 expression.
    Zhu Y; Cai L; Guo J; Chen N; Yi X; Zhao Y; Cai J; Wang Z
    Tumour Biol; 2016 Oct; 37(10):14009-14023. PubMed ID: 27492604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axl molecular targeting counteracts aggressiveness but not platinum-resistance of ovarian carcinoma cells.
    Corno C; Gatti L; Arrighetti N; Carenini N; Zaffaroni N; Lanzi C; Perego P
    Biochem Pharmacol; 2017 Jul; 136():40-50. PubMed ID: 28404378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer.
    Sun W; Li J; Zhou L; Han J; Liu R; Zhang H; Ning T; Gao Z; Liu B; Chen X; Ba Y
    Theranostics; 2020; 10(5):1981-1996. PubMed ID: 32104496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dicer, Drosha, and outcomes in patients with ovarian cancer.
    Merritt WM; Lin YG; Han LY; Kamat AA; Spannuth WA; Schmandt R; Urbauer D; Pennacchio LA; Cheng JF; Nick AM; Deavers MT; Mourad-Zeidan A; Wang H; Mueller P; Lenburg ME; Gray JW; Mok S; Birrer MJ; Lopez-Berestein G; Coleman RL; Bar-Eli M; Sood AK
    N Engl J Med; 2008 Dec; 359(25):2641-50. PubMed ID: 19092150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting miR-21-3p inhibits proliferation and invasion of ovarian cancer cells.
    Báez-Vega PM; Echevarría Vargas IM; Valiyeva F; Encarnación-Rosado J; Roman A; Flores J; Marcos-Martínez MJ; Vivas-Mejía PE
    Oncotarget; 2016 Jun; 7(24):36321-36337. PubMed ID: 27166999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.